325 related articles for article (PubMed ID: 22610826)
1. Body mass index and survival in patients with renal cell carcinoma: a clinical-based cohort and meta-analysis.
Choi Y; Park B; Jeong BC; Seo SI; Jeon SS; Choi HY; Adami HO; Lee JE; Lee HM
Int J Cancer; 2013 Feb; 132(3):625-34. PubMed ID: 22610826
[TBL] [Abstract][Full Text] [Related]
2. Obesity is associated with an improved cancer-specific survival, but an increased rate of postoperative complications after surgery for renal cell carcinoma.
Rogde AJ; Gudbrandsdottir G; Hjelle KM; Sand KE; Bostad L; Beisland C
Scand J Urol Nephrol; 2012 Oct; 46(5):348-57. PubMed ID: 22530756
[TBL] [Abstract][Full Text] [Related]
3. Extreme obesity does not predict poor cancer outcomes after surgery for renal cell cancer.
Blute ML; Zorn K; Grimes M; Shi F; Downs TM; Jarrard DF; Best SL; Richards K; Nakada SY; Abel EJ
BJU Int; 2016 Sep; 118(3):399-407. PubMed ID: 26589741
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of Body Mass Index According to Histologic Subtype in Nonmetastatic Renal Cell Carcinoma: A Large Cohort Analysis.
Lee WK; Hong SK; Lee S; Kwak C; Oh JJ; Jeong CW; Kim YJ; Kang SH; Hong SH; Byun SS
Clin Genitourin Cancer; 2015 Oct; 13(5):461-8. PubMed ID: 25990340
[TBL] [Abstract][Full Text] [Related]
5. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
6. Impact of body mass index and weight loss on cancer-specific and overall survival in patients with surgically resected renal cell carcinoma.
Brookman-May S; Kendel F; Hoschke B; Wieland WF; Burger M; Rössler W; May M
Scand J Urol Nephrol; 2011 Feb; 45(1):5-14. PubMed ID: 20846080
[TBL] [Abstract][Full Text] [Related]
7. Preoperative metastatic status, level of thrombus and body mass index predict overall survival in patients undergoing nephrectomy and inferior vena cava thrombectomy.
Spiess PE; Kurian T; Lin HY; Rawal B; Kim T; Sexton WJ; Pow-Sang JM
BJU Int; 2012 Dec; 110(11 Pt B):E470-4. PubMed ID: 22519938
[TBL] [Abstract][Full Text] [Related]
8. Impact of body mass index in Korean patients with renal cell carcinoma.
Sung HH; Jeon SS; Park SY; Jeong BC; Seo SI; Lee HM; Choi HY
Cancer Causes Control; 2012 Mar; 23(3):505-11. PubMed ID: 22350955
[TBL] [Abstract][Full Text] [Related]
9. The influence of body mass index on the long-term survival of patients with renal cell carcinoma after tumour nephrectomy.
Haferkamp A; Pritsch M; Bedke J; Wagener N; Pfitzenmaier J; Buse S; Hohenfellner M
BJU Int; 2008 May; 101(10):1243-6. PubMed ID: 18261150
[TBL] [Abstract][Full Text] [Related]
10. Body mass index as independent predictor of overall survival in patients with advanced renal cell carcinoma at start of systemic treatment-Analyses from the German clinical RCC-Registry.
Goebell PJ; Müller L; Hübner A; Harich HD; Boller E; Koska M; Jänicke M; Marschner N;
Urol Oncol; 2018 Oct; 36(10):470.e1-470.e9. PubMed ID: 30131294
[TBL] [Abstract][Full Text] [Related]
11. Influence of nutritional deficiency on prognosis of renal cell carcinoma (RCC).
Ko K; Park YH; Lee JW; Ku JH; Kwak C; Kim HH
BJU Int; 2013 Oct; 112(6):775-80. PubMed ID: 24028765
[TBL] [Abstract][Full Text] [Related]
12. Increased preoperative levels of plasma fibrinogen and D dimer in patients with renal cell carcinoma is associated with poor survival and adverse tumor characteristics.
Erdem S; Amasyali AS; Aytac O; Onem K; Issever H; Sanli O
Urol Oncol; 2014 Oct; 32(7):1031-40. PubMed ID: 25027687
[TBL] [Abstract][Full Text] [Related]
13. Body Mass Index and Survival in a Prospective Randomized Trial of Localized High-Risk Renal Cell Carcinoma.
Donin NM; Pantuck A; Klöpfer P; Bevan P; Fall B; Said J; Belldegrun AS; Chamie K
Cancer Epidemiol Biomarkers Prev; 2016 Sep; 25(9):1326-32. PubMed ID: 27418270
[TBL] [Abstract][Full Text] [Related]
14. Multi-institutional analysis of localized renal cell carcinoma that demonstrates the impact of diabetic status on prognosis after nephrectomy.
Ha YS; Kim WT; Yun SJ; Lee SC; Kim WJ; Park YH; Kang SH; Hong SH; Byun SS; Kim YJ
Ann Surg Oncol; 2013 Oct; 20(11):3662-8. PubMed ID: 23907313
[TBL] [Abstract][Full Text] [Related]
15. Does overweight impact on the prognosis of patients with renal cell carcinoma? A single center experience of 683 patients.
Schips L; Lipsky K; Zigeuner R; Gidaro S; Salfellner M; Rehak P; Pummer K; Hubmer G
J Surg Oncol; 2004 Nov; 88(2):57-61; discussion 61-2. PubMed ID: 15499606
[TBL] [Abstract][Full Text] [Related]
16. Laparoscopic renal cryoablation using ultrathin 17-gauge cryoprobes: mid-term oncological and functional results.
Beemster PW; Barwari K; Mamoulakis C; Wijkstra H; de la Rosette JJ; Laguna MP
BJU Int; 2011 Aug; 108(4):577-82. PubMed ID: 21044249
[TBL] [Abstract][Full Text] [Related]
17. Age-dependent prognostic value of body mass index for non-metastatic clear cell renal cell carcinoma: A large multicenter retrospective analysis.
Byun SS; Hwang EC; Kang SH; Hong SH; Chung J; Kwon TG; Kim HH; Kwak C; Kim YJ; Lee WK
J Surg Oncol; 2018 Jul; 118(1):199-205. PubMed ID: 29949668
[TBL] [Abstract][Full Text] [Related]
18. Epidemiologic trends in renal cell carcinoma in the cytokine and post-cytokine eras: a registry analysis of 28,252 patients.
Shek D; Tomlinson B; Brown M; Brunson A; Pan CX; Lara PN
Clin Genitourin Cancer; 2012 Jun; 10(2):93-8. PubMed ID: 22382008
[TBL] [Abstract][Full Text] [Related]
19. Greater body mass index is associated with better pathologic features and improved outcome among patients treated surgically for clear cell renal cell carcinoma.
Parker AS; Lohse CM; Cheville JC; Thiel DD; Leibovich BC; Blute ML
Urology; 2006 Oct; 68(4):741-6. PubMed ID: 17070345
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of prognostic nutritional index in renal cell carcinomas.
Tang Y; Liang J; Liu Z; Zhang R; Zou Z; Wu K; Lu Y; Wei X
Medicine (Baltimore); 2021 Mar; 100(10):e25127. PubMed ID: 33725913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
